Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

NCT02608112 · clinicaltrials.gov ↗

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche